What is the Oxygenta Pharmaceutical Ltd share price today?

The share price of BSE:OXYGENTAPH-XT on 01 Oct 2026 (as of 15:06:30 IST) is ₹48.

What is the BSE:OXYGENTAPH-XT 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:OXYGENTAPH-XT 52 week high low range shows a high of ₹71.75 and a low of ₹43.

What is the Oxygenta Pharmaceutical Ltd market cap?

As on 01 Oct 2026, Oxygenta Pharmaceutical Ltd market cap is ₹1783340000.

What is the shareholding pattern of Oxygenta Pharmaceutical Ltd Stock?

The shareholding pattern of Oxygenta Pharmaceutical Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 56.54% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0.03% Retail & Others: 43.43% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Oxygenta Pharmaceutical Ltd?

The Price-to-Earnings (PE) ratio of Oxygenta Pharmaceutical Ltd is 0, and the Price-to-Book (PB) ratio is -4.1916, as on 01 Oct 2026.

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+0.00%

1 Week

-0.76%

1 Month

+0.19%

3 Month

-9.19%

6 Month

-16.07%

YTD

-15.67%

1 Year

-27.47%

5 Year

NA

10 Year

NA

Max

+93.62%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

47.05

45.16

43.00

High

47.05

49.30

71.59

About

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

No results found

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

Financial overview

Peer Comparison

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Balance Sheet

Consolidated

Standalone

₹

%

Cash Flow

Consolidated

Standalone

₹

%

Fundamental Ratios

Consolidated

Standalone

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

Shareholding summary

No data available

Promoters

—

FII

—

DII

—

MF

—

Others

—

Promoters

FII

DII

MF

Others

Quarterly

Yearly

No data available

Shareholding Pattern

Quarterly

Yearly

No results found

Bulk & block deals

No results found

Insider trading & SAST

No results found

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

Registrars

Management

Details

BSE

NSE

ISIN

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

Corporate filings & documents

No corporate filings & documents found

Oxygenta Pharmaceutical Share Price

47.05+0.00 (+0.00%)

-27.47% past 1 Year

News

Kotak Maintains Buy On SBI With Rs 1250 Target After Strong Q2 Earnings

Equity

SBIN

4 Nov 2026

Nomura Maintains Neutral Rating On SBI With Rs 1100 Target Price

Equity

SBIN

4 Nov 2026

Citi Maintains Buy Rating On SBI With Rs 1300 Target Price

Equity

SBIN

4 Nov 2026

HSBC Maintains Buy Rating On SBI With Rs 1220 Target Price

Equity

SBIN

4 Nov 2026

Bernstein Maintains Market Perform On SBI Amid Softer Underlying Earnings Performance

Equity

SBIN

4 Nov 2026

CLSA Maintains Outperform Rating On SBI After Strong Q2 Operating Performance

Equity

SBIN

4 Nov 2026

Macquarie Maintains Outperform Rating On SBI With Rs 1220 Target

Equity

SBIN

4 Nov 2026

UBS Maintains Neutral View On SBI After Mixed Q2 Operating Performance

Equity

SBIN

4 Nov 2026

Neuland Laboratories Reports Weak Q2 Amid Commercial CMS Order Volatility

Equity

NEULANDLAB

4 Nov 2026

Solar Industries Q2 Growth Beats Estimates, Goldman Sachs Retains Buy Rating

Equity

SOLARINDS

4 Nov 2026

Angel One October funding book and client base show strong year on year growth

Equity

ANGELONE

4 Nov 2026

Citi Retains Sell Rating, Cuts Bata India Target Price To Rs 550

Equity

BATAINDIA

4 Nov 2026

CLSA Maintains Outperform Rating On Max Healthcare With Rs 1160 Target

Equity

MAXHEALTH

4 Nov 2026

Lupin Reports Lower Q2 EBITDA and Margin Despite Stronger Sales Growth

Equity

LUPIN

4 Nov 2026

MGL Q2 FY27 Earnings Miss Estimates Amid Higher Gas Costs

Equity

MGL

4 Nov 2026

Lupin Q2 Profit Declines Despite Revenue Growth Amid Margin Pressure

Equity

LUPIN

4 Nov 2026

Nomura Maintains Neutral On IGL, Cuts Target Price To Rs 140

Equity

IGL

4 Nov 2026

Parag Milk Foods Reports Higher Revenue But Lower Q2 Consolidated Profit

Equity

PARAGMILK

4 Nov 2026

Nomura Maintains Buy On BEL With Rs 530 Target Price

Equity

BEL

4 Nov 2026

Parag Milk Foods Reports Strong Second Quarter EBITDA Growth And Margin Expansion

Equity

PARAGMILK

4 Nov 2026

Oxygenta Pharmaceutical Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Oxygenta Pharmaceutical Share Price

Oxygenta Pharmaceutical Share Price

Financial overview

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Oxygenta Pharmaceutical Share Price

Oxygenta Pharmaceutical Share Price

Oxygenta Pharmaceutical Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Oxygenta Pharmaceutical Share Price

Corporate Actions

Company details

Oxygenta Pharmaceutical Share Price

Corporate filings & documents

Oxygenta Pharmaceutical Share Price

News

Kotak Maintains Buy On SBI With Rs 1250 Target After Strong Q2 Earnings

Nomura Maintains Neutral Rating On SBI With Rs 1100 Target Price

Citi Maintains Buy Rating On SBI With Rs 1300 Target Price

HSBC Maintains Buy Rating On SBI With Rs 1220 Target Price

Bernstein Maintains Market Perform On SBI Amid Softer Underlying Earnings Performance

CLSA Maintains Outperform Rating On SBI After Strong Q2 Operating Performance

Macquarie Maintains Outperform Rating On SBI With Rs 1220 Target

UBS Maintains Neutral View On SBI After Mixed Q2 Operating Performance

Neuland Laboratories Reports Weak Q2 Amid Commercial CMS Order Volatility

Solar Industries Q2 Growth Beats Estimates, Goldman Sachs Retains Buy Rating

Angel One October funding book and client base show strong year on year growth

Citi Retains Sell Rating, Cuts Bata India Target Price To Rs 550

CLSA Maintains Outperform Rating On Max Healthcare With Rs 1160 Target

Lupin Reports Lower Q2 EBITDA and Margin Despite Stronger Sales Growth

MGL Q2 FY27 Earnings Miss Estimates Amid Higher Gas Costs

Lupin Q2 Profit Declines Despite Revenue Growth Amid Margin Pressure

Nomura Maintains Neutral On IGL, Cuts Target Price To Rs 140

Parag Milk Foods Reports Higher Revenue But Lower Q2 Consolidated Profit

Nomura Maintains Buy On BEL With Rs 530 Target Price

Parag Milk Foods Reports Strong Second Quarter EBITDA Growth And Margin Expansion

Oxygenta Pharmaceutical Ltd Share Price Today

Oxygenta Pharmaceutical Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator